213 related articles for article (PubMed ID: 35570263)
21. The spider toxin Phα1β recombinant possesses strong analgesic activity.
Rigo FK; Trevisan G; De Prá SD; Cordeiro MN; Borges MH; Silva JF; Santa Cecilia FV; de Souza AH; de Oliveira Adamante G; Milioli AM; de Castro Junior CJ; Ferreira J; Gomez MV
Toxicon; 2017 Jul; 133():145-152. PubMed ID: 28526335
[TBL] [Abstract][Full Text] [Related]
22. Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat.
Scott DA; Wright CE; Angus JA
Eur J Pharmacol; 2002 Sep; 451(3):279-86. PubMed ID: 12242089
[TBL] [Abstract][Full Text] [Related]
23. Spinal actions of ω-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model.
Jayamanne A; Jeong HJ; Schroeder CI; Lewis RJ; Christie MJ; Vaughan CW
Br J Pharmacol; 2013 Sep; 170(2):245-54. PubMed ID: 23713957
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the antinociceptive effect of PhTx3-4, a toxin from Phoneutria nigriventer, in models of thermal, chemical and incisional pain in mice.
da Silva JF; Castro-Junior CJ; Oliveira SM; Dalmolin GD; Silva CR; Vieira LB; Diniz DM; Cordeiro Mdo N; Ferreira J; Souza AH; Gomez MV
Toxicon; 2015 Dec; 108():53-61. PubMed ID: 26435340
[TBL] [Abstract][Full Text] [Related]
25. Recombinant peptide derived from the venom the Phoneutria nigriventer spider relieves nociception by nerve deafferentation.
Antunes FTT; Angelo SG; Dallegrave E; Picada JN; Marroni NP; Schemitt E; Ferraz AG; Gomez MV; de Souza AH
Neuropeptides; 2020 Feb; 79():101980. PubMed ID: 31711615
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of voltage-gated calcium channel blockers on calcium channel alpha-2-delta-1 subunit protein-mediated nociception.
Chang E; Chen X; Kim M; Gong N; Bhatia S; Luo ZD
Eur J Pain; 2015 May; 19(5):639-48. PubMed ID: 25158907
[TBL] [Abstract][Full Text] [Related]
27. The spinal inhibition of N-type voltage-gated calcium channels selectively prevents scratching behavior in mice.
Maciel IS; Azevedo VM; Pereira TC; Bogo MR; Souza AH; Gomez MV; Campos MM
Neuroscience; 2014 Sep; 277():794-805. PubMed ID: 25108164
[TBL] [Abstract][Full Text] [Related]
28. Antinociceptive effects of intrathecally administered huwentoxin-I, a selective N-type calcium channel blocker, in the formalin test in conscious rats.
Chen JQ; Zhang YQ; Dai J; Luo ZM; Liang SP
Toxicon; 2005 Jan; 45(1):15-20. PubMed ID: 15581678
[TBL] [Abstract][Full Text] [Related]
29. Acute Toxicity of the Recombinant and Native Phα1β Toxin: New Analgesic from
Dallegrave E; Taschetto E; Bainy Leal M; Techera Antunes FT; Gomez MV; Hubner de Souza A
Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30545036
[TBL] [Abstract][Full Text] [Related]
30. Spider peptide Phα1β induces analgesic effect in a model of cancer pain.
Rigo FK; Trevisan G; Rosa F; Dalmolin GD; Otuki MF; Cueto AP; de Castro Junior CJ; Romano-Silva MA; Cordeiro Mdo N; Richardson M; Ferreira J; Gomez MV
Cancer Sci; 2013 Sep; 104(9):1226-30. PubMed ID: 23718272
[TBL] [Abstract][Full Text] [Related]
31. Analgesic effect in rodents of native and recombinant Ph alpha 1beta toxin, a high-voltage-activated calcium channel blocker isolated from armed spider venom.
Souza AH; Ferreira J; Cordeiro MDN; Vieira LB; De Castro CJ; Trevisan G; Reis H; Souza IA; Richardson M; Prado MAM; Prado VF; Gomez MV
Pain; 2008 Nov; 140(1):115-126. PubMed ID: 18774645
[TBL] [Abstract][Full Text] [Related]
32. Effects of intrathecal administration of ziconotide, a selective neuronal N-type calcium channel blocker, on mechanical allodynia and heat hyperalgesia in a rat model of postoperative pain.
Wang YX; Pettus M; Gao D; Phillips C; Scott Bowersox S
Pain; 2000 Feb; 84(2-3):151-8. PubMed ID: 10666519
[TBL] [Abstract][Full Text] [Related]
33. An evaluation of intrathecal ziconotide for the treatment of chronic pain.
Jain KK
Expert Opin Investig Drugs; 2000 Oct; 9(10):2403-10. PubMed ID: 11060815
[TBL] [Abstract][Full Text] [Related]
34. Antinociceptive effect of a novel armed spider peptide Tx3-5 in pathological pain models in mice.
Oliveira SM; Silva CR; Trevisan G; Villarinho JG; Cordeiro MN; Richardson M; Borges MH; Castro CJ; Gomez MV; Ferreira J
Pflugers Arch; 2016 May; 468(5):881-94. PubMed ID: 26898377
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic potential of RQ-00311651, a novel T-type Ca2+ channel blocker, in distinct rodent models for neuropathic and visceral pain.
Sekiguchi F; Kawara Y; Tsubota M; Kawakami E; Ozaki T; Kawaishi Y; Tomita S; Kanaoka D; Yoshida S; Ohkubo T; Kawabata A
Pain; 2016 Aug; 157(8):1655-1665. PubMed ID: 27023424
[TBL] [Abstract][Full Text] [Related]
36. Synergistic antinociceptive effect of a calcium channel blocker and a TRPV1 blocker in an acute pain model in mice.
Palhares MR; Silva JF; Rezende MJS; Santos DC; Silva-Junior CA; Borges MH; Ferreira J; Gomez MV; Castro-Junior CJ
Life Sci; 2017 Aug; 182():122-128. PubMed ID: 28629730
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective effect of CTK 01512-2 recombinant toxin at the spinal cord in a model of Huntington's disease.
Joviano-Santos JV; Valadão PAC; Magalhães-Gomes MPS; Fernandes LF; Diniz DM; Machado TCG; Soares KB; Ladeira MS; Massensini AR; Gomez MV; Miranda AS; Tápia JC; Guatimosim C
Exp Physiol; 2022 Aug; 107(8):933-945. PubMed ID: 35478205
[TBL] [Abstract][Full Text] [Related]
38. Phα1β Spider Toxin Reverses Glial Structural Plasticity Upon Peripheral Inflammation.
Tenza-Ferrer H; Magno LAV; Romano-Silva MA; da Silva JF; Gomez MV
Front Cell Neurosci; 2019; 13():306. PubMed ID: 31354431
[TBL] [Abstract][Full Text] [Related]
39. Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic Pain.
Tzschentke TM; Linz K; Frosch S; Christoph T
Pain Pract; 2017 Nov; 17(8):1032-1041. PubMed ID: 28112482
[TBL] [Abstract][Full Text] [Related]
40. Antinociceptive effects of the marine snail peptides conantokin-G and conotoxin MVIIA alone and in combination in rat models of pain.
Hama A; Sagen J
Neuropharmacology; 2009 Feb; 56(2):556-63. PubMed ID: 19010337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
